These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096 [TBL] [Abstract][Full Text] [Related]
4. Effects of N-methyl-D-aspartate antagonists on the cough reflex. Kamei J; Tanihara H; Igarashi H; Kasuya Y Eur J Pharmacol; 1989 Sep; 168(2):153-8. PubMed ID: 2691260 [TBL] [Abstract][Full Text] [Related]
5. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253 [TBL] [Abstract][Full Text] [Related]
6. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Foster AC; Wong EH Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170 [TBL] [Abstract][Full Text] [Related]
10. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801. Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964 [TBL] [Abstract][Full Text] [Related]
11. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Huettner JE; Bean BP Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1307-11. PubMed ID: 2448800 [TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. Koek W; Woods JH; Colpaert FC J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Marrannes R; Willems R; De Prins E; Wauquier A Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364 [TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception. DeLander GE; Wahl JJ Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511 [TBL] [Abstract][Full Text] [Related]
16. The N-methyl-D-aspartate antagonists aminophosphonovaleric acid and MK-801 reduce anoxic damage to dentate granule and CA1 pyramidal cells in the rat hippocampal slice. Kass IS; Chambers G; Cottrell JE Exp Neurol; 1989 Feb; 103(2):116-22. PubMed ID: 2563246 [TBL] [Abstract][Full Text] [Related]
17. Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801. Hahn JS; Aizenman E; Lipton SA Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6556-60. PubMed ID: 2901101 [TBL] [Abstract][Full Text] [Related]
18. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects. France CP; Woods JH; Ornstein P Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134 [TBL] [Abstract][Full Text] [Related]
19. Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain. Silverstein FS; McDonald JW; Bommarito M; Johnston MV Stroke; 1990 Feb; 21(2):310-5. PubMed ID: 1968295 [TBL] [Abstract][Full Text] [Related]